upcoming events
BTK inhibitors, what are the facts and what are the differences?
Objectives: CLL disease pathophysiology and BTK inhibitors efficacy data.
How to avoid premature treatment discontinuation?
Objectives: How to avoid premature treatment discontinuation of IMBRUVICA and other BTKi?
How I treat Relapsed CLL patient?
Objectives: When to start you relapsed refractory therapy?
is there a place for BMT in CLL?
Objectives: Is there a place for BMT in CLL? Real cases: Is it a CLL progression....
Webinars
Lorem Ipsum is simply dummy text of the printing…
September 28, 2016
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's…
Lorem Ipsum is simply dummy text of the printing…
September 23, 2016
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's…
Lorem Ipsum is simply dummy text of the printing…
September 20, 2016
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's…